Franklin Genomic Advancements ETF (HELX)

Market Cap: 10M

Fund manager confidence

Based on 2024 Q1 SEC filings by fund managers ($100M+ AUM)

0% more funds holding

Funds holding: 10 [Q4 2023] → 10 (+0) [Q1 2024]

0% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 2

8.63% less ownership

Funds ownership: 40.23% [Q4 2023] → 31.6% (-8.63%) [Q1 2024]

28% less capital invested

Capital invested by funds: $4.29M [Q4 2023] → $3.11M (-$1.18M) [Q1 2024]

80% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 5